DUD · HIGH LIVE Called October 20, 2026

INDICAID COVID-19/Flu A and B 3-in-1 Combo Rapid Antigen Test – FDA 510(k)-Cleared - Results in 10 Minutes - Made in USA - 5 Tests - OTC for Home and Business - Easy to Use - FSA/HSA Approved Product

Industrial & Scientific · B0FDJW4P3B

This product's Amazon sales rank jumped 3× over its own pre-surge baseline. We called it a dud: the data said this spike would fade fast.

AT 3 WEEKS
⏳ VERDICT ~NOV 06, 2026

This call is still inside its 3-week window. The verdict lands ~Nov 06, 2026 — graded against the fixed bar below, right or wrong, and stays on the board either way.

AT 6 WEEKS
⏳ VERDICT ~NOV 28, 2026

The six-week verdict lands ~Nov 28, 2026, graded against the same bar.

call madegrade daySep 07OctNov

Amazon sales rank, inverted — higher = selling better. Dashed line = the day we made the call.

HOW THIS CALL IS GRADED

Every call is graded against the same fixed bar, set before the call is made: three weeks after the surge began, is the product still selling at at least 2× its pre-trend pace AND ranking among its category's proven sellers? Clears both = a keeper call was right. Fails either = a dud call was right. No judgment calls, no moved goalposts. The six-week verdict asks that same question again over days 31–42 instead of 10–21 — nothing is redefined, it is simply asked later, because sourcing takes weeks. This call was posted publicly in real time, before the outcome existed.

Scryup calls Amazon trends — keeper or dud — on day 3, from the data.

Every call is posted publicly and graded in the open at three weeks and again at six, hits and misses both. See the whole board, or check any US product free — paste an ASIN and we'll email you the keeper-or-dud call.

See the full track record → Which Q4 trends repeat → Follow the calls on X @scryup